Cargando…
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
Combined chemotherapeutic treatment is the method of choice for advanced and metastatic gastric tumors. However, resistance to chemotherapeutic agents is one of the main challenges for the efficient gastric cancer (GC) treatment. Cisplatin (CDDP) is used as an important regimen of chemotherapy for G...
Autores principales: | Zangouei, Amir Sadra, Moghbeli, Meysam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182944/ https://www.ncbi.nlm.nih.gov/pubmed/34099061 http://dx.doi.org/10.1186/s41021-021-00192-4 |
Ejemplares similares
-
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
por: Zangouei, Amir Sadra, et al.
Publicado: (2021) -
MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023) -
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
por: Hamidi, Amir Abbas, et al.
Publicado: (2022) -
MicroRNAs as the critical regulators of Forkhead box protein family during gynecological and breast tumor progression and metastasis
por: Taghehchian, Negin, et al.
Publicado: (2023) -
Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells
por: Zangouei, Amir Sadra, et al.
Publicado: (2020)